We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+0.09%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$15.4B
AUM Growth
-$4.25B
(-22%)
Cap. Flow
-$11.2B
Cap. Flow
% of AUM
-72.83%
Top 10 Holdings %
Top 10 Hldgs %
18.29%
Holding
643
New
38
Increased
264
Reduced
90
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$129M |
| 2 |
American International
AIG
|
+$82.2M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$74.9M |
| 5 |
Humana
HUM
|
+$67.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$92.5M |
| 2 |
Wells Fargo
WFC
|
+$55.4M |
| 3 |
AMT.PRB
American Tower Corporation
AMT.PRB
|
+$50.1M |
| 4 |
Apple
AAPL
|
+$48.6M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$36.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.23% |
| 2 | Technology | 9.26% |
| 3 | Healthcare | 8.87% |
| 4 | Communication Services | 6.39% |
| 5 | Consumer Discretionary | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
TransUnion
TRU
$14.8B
| $20.1M | 0.13% |
354,347
-13,969
| -4% | -$806K |
|
|
AL
152
DELISTED
Air Lease Corp
AL
| $20M | 0.13% |
469,622
-264,899
| -36% | -$12.2M |
|
153
UBS Group
UBS
$170B
| $19.8M | 0.13% |
1,123,000
+329,000
| +41% | +$6.25M |
|
154
Royal Caribbean
RCL
$78.7B
| $19.8M | 0.13% |
168,396
+43,330
| +35% | +$5.47M |
|
155
CALL
TSMC
TSM
$2.09T
| $19.7M | 0.13% |
+450,000
| New | +$19.6M |
|
|
WCN
156
Waste Connections
WCN
$42.8B
| $19.3M | 0.13% |
269,442
-5,438
| -2% | -$387K |
|
157
Alibaba
BABA
$269B
| $19.3M | 0.13% |
105,077
-5,000
| -5% | -$941K |
|
158
BP
BP
$113B
| $19.3M | 0.13% |
511,206
-7,704
| -1% | -$290K |
|
159
Eaton
ETN
$157B
| $18.9M | 0.12% |
236,050
+2,223
| +1% | +$182K |
|
160
Tesla
TSLA
$1.24T
| $18.5M | 0.12% |
1,044,495
-612,480
| -37% | -$13.5M |
|
161
Microchip Technology
MCHP
$42.8B
| $18.4M | 0.12% |
403,060
-1,414
| -0.3% | -$65.2K |
|
162
Eli Lilly
LLY
$1.07T
| $18.2M | 0.12% |
235,272
+4,729
| +2% | +$381K |
|
163
S&P Global
SPGI
$126B
| $18.1M | 0.12% |
+94,790
| New | +$17.5M |
|
164
PUT
Invesco QQQ Trust
QQQ
$455B
| $17.9M | 0.12% |
111,500
-43,138,500
| -100% | -$7.13B |
|
165
iShares Biotechnology ETF
IBB
$9.31B
| $17.8M | 0.12% |
166,820
-24,385
| -13% | -$2.7M |
|
166
iShares Russell 2000 ETF
IWM
$80.9B
| $17.7M | 0.12% |
+116,735
| New | +$18M |
|
167
Agilent Technologies
A
$39.1B
| $17.6M | 0.11% |
262,345
+58,090
| +28% | +$4.07M |
|
168
Northern Trust
NTRS
$22.2B
| $17.3M | 0.11% |
167,660
+146,435
| +690% | +$15.3M |
|
169
Carnival Corporation Ltd
CCL
$36.1B
| $16.7M | 0.11% |
254,016
-35,331
| -12% | -$2.4M |
|
170
CALL
CarMax
KMX
$8.27B
| $16.6M | 0.11% |
+267,500
| New | +$17.5M |
|
|
AET
171
DELISTED
Aetna Inc
AET
| $16.5M | 0.11% |
97,669
-11,689
| -11% | -$2.1M |
|
|
DFS
172
DELISTED
Discover Financial Services
DFS
| $16.3M | 0.11% |
226,213
-462,729
| -67% | -$35.7M |
|
173
PACCAR
PCAR
$69.6B
| $16.3M | 0.11% |
368,355
| – | – |
|
174
Mohawk Industries
MHK
$6.9B
| $16.1M | 0.1% |
69,259
-292
| -0.4% | -$75.2K |
|
|
WBA
175
DELISTED
Walgreens Boots Alliance
WBA
| $16M | 0.1% |
244,577
-50,313
| -17% | -$3.59M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, Calamos Advisors held 643 positions worth $15.4B, down 22% from $19.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Calamos Advisors withdrew a net $11.2B in Q1 2018, closing 44 positions and reducing 90 holdings. Its most notable exit was Allergan plc, an estimated $92.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 8.5% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Humana worth $67.1M.
- Calamos Advisors's largest Q1 2018 buy was Humana: 249,674 shares worth $67.1M.
- Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $129M increase.
- Calamos Advisors's biggest Q1 2018 reduction was Wells Fargo, cutting an estimated $55.4M.
- Calamos Advisors fully exited Allergan plc in Q1 2018, selling an estimated $92.5M.
- Calamos Advisors's ten largest holdings make up 18% of its $15.4B portfolio in Q1 2018.
- Calamos Advisors opened 38 new positions and closed 44 in Q1 2018.
- Calamos Advisors's portfolio value fell 22% quarter-over-quarter to $15.4B.
Based on Calamos Advisors's 13F filing for Q1 2018, filed 13 Apr 2018.